We are live on
!
Find out more
N
Natixis Portfolio holdings
AUM
$28B
1-Year Est. Return
26.79%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Fund
S&P 500
This Quarter
Est. Return
+9.03%
1 Year Est. Return
+26.79%
3 Year Est. Return
+97.72%
5 Year Est. Return
+108.83%
10 Year Est. Return
+452.99%
AUM
$16.1B
AUM Growth
+$610M
(+3.9%)
Cap. Flow
-$574M
Cap. Flow
% of AUM
-3.56%
Top 10 Holdings %
Top 10 Hldgs %
22.53%
Holding
1,027
New
221
Increased
307
Reduced
274
Closed
203
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$170M |
| 2 |
Lyft
LYFT
|
+$140M |
| 3 |
Alibaba
BABA
|
+$112M |
| 4 |
Home Depot
HD
|
+$111M |
| 5 |
AbbVie
ABBV
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$404M |
| 2 |
Microsoft
MSFT
|
+$327M |
| 3 |
Apple
AAPL
|
+$308M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$264M |
| 5 |
CELG
Celgene Corp
CELG
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.33% |
| 2 | Financials | 11.99% |
| 3 | Consumer Discretionary | 11.4% |
| 4 | Healthcare | 10.63% |
| 5 | Industrials | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXE
601
DELISTED
Anixter International Inc
AXE
| $1.48M | 0.01% |
+16,000
| New | +$1.3M |
|
602
Autoliv
ALV
$8.6B
| $1.46M | 0.01% |
17,279
+14,010
| +429% | +$1.15M |
|
603
Williams-Sonoma
WSM
$26.7B
| $1.46M | 0.01% |
+39,650
| New | +$1.38M |
|
604
3D Systems Corp
DDD
$420M
| $1.45M | 0.01% |
+166,938
| New | +$1.45M |
|
605
Equinix
EQIX
$107B
| $1.44M | 0.01% |
2,480
+1,260
| +103% | +$708K |
|
606
Molina Healthcare
MOH
$10.3B
| $1.43M | 0.01% |
10,501
+8,339
| +386% | +$1.05M |
|
607
Zimmer Biomet
ZBH
$17.7B
| $1.42M | 0.01% |
+9,840
| New | +$1.36M |
|
608
Pembina Pipeline
PBA
$29.9B
| $1.4M | 0.01% |
37,654
+9,924
| +36% | +$355K |
|
|
MRO
609
DELISTED
Marathon Oil Corporation
MRO
| $1.38M | 0.01% |
+102,472
| New | +$1.25M |
|
|
FOE
610
DELISTED
Ferro Corporation
FOE
| $1.37M | 0.01% |
+92,000
| New | +$1.19M |
|
|
CBPX
611
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $1.36M | 0.01% |
+37,378
| New | +$1.23M |
|
612
Inogen
INGN
$167M
| $1.36M | 0.01% |
+20,000
| New | +$1.25M |
|
613
Vanguard Real Estate ETF
VNQ
$39.9B
| $1.35M | 0.01% |
14,683
-7,499
| -34% | -$694K |
|
|
UNVR
614
DELISTED
Univar Solutions Inc.
UNVR
| $1.35M | 0.01% |
+56,019
| New | +$1.27M |
|
615
Qorvo
QRVO
$7.63B
| $1.34M | 0.01% |
+11,521
| New | +$1.11M |
|
616
Invesco S&P 500 Quality ETF
SPHQ
$19.4B
| $1.32M | 0.01% |
36,236
+345
| +1% | +$12K |
|
617
Invesco Mortgage Capital
IVR
$776M
| $1.32M | 0.01% |
+7,924
| New | +$1.27M |
|
618
JELD-WEN Holding
JELD
$94.8M
| $1.31M | 0.01% |
+56,500
| New | +$1.16M |
|
619
National Health Investors
NHI
$3.9B
| $1.3M | 0.01% |
16,000
| – | – |
|
620
Codexis
CDXS
$135M
| $1.29M | 0.01% |
80,400
+30,800
| +62% | +$456K |
|
621
Cabot Corp
CBT
$4.65B
| $1.27M | 0.01% |
27,091
+11,529
| +74% | +$535K |
|
622
Crane NXT
CXT
$3.04B
| $1.26M | 0.01% |
41,861
-187,592
| -82% | -$5.34M |
|
623
Mid-America Apartment Communities
MAA
$15.6B
| $1.26M | 0.01% |
9,622
+1,301
| +16% | +$174K |
|
624
Invesco
IVZ
$13.3B
| $1.25M | 0.01% |
69,801
+13,931
| +25% | +$238K |
|
625
Pacific Biosciences
PACB
$422M
| $1.24M | 0.01% |
239,831
+114,131
| +91% | +$580K |
|
Similar funds
TWC
FDCDDQ
PCH
NA
Natixis's Q4 2019 Portfolio in Review
As of Q4 2019, Natixis held 1,027 positions worth $16.1B, up 3.9% from $15.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Natixis withdrew a net $574M in Q4 2019, closing 203 positions and reducing 274 holdings. Its most notable exit was Celgene Corp, an estimated $222M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Natixis opened a new position in Centene worth $100M.
- Natixis's largest Q4 2019 buy was Centene: 1,592,267 shares worth $100M.
- Natixis added most to State Street SPDR S&P Biotech ETF in Q4 2019, an estimated $170M increase.
- Natixis's biggest Q4 2019 reduction was Meta Platforms (Facebook), cutting an estimated $404M.
- Natixis fully exited Celgene Corp in Q4 2019, selling an estimated $222M.
- Natixis's ten largest holdings make up 23% of its $16.1B portfolio in Q4 2019.
- Natixis opened 221 new positions and closed 203 in Q4 2019.
- Natixis's portfolio value rose 3.9% quarter-over-quarter to $16.1B.
Based on Natixis's 13F filing for Q4 2019, filed 14 Feb 2020.